<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To evaluate clinical and biologic features of children with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) treated in Moscow, Russia, we studied 53 cases treated in the Republican Children's Hospital from 1990 to 1994 </plain></SENT>
<SENT sid="1" pm="."><plain>Histologic examination disclosed a predominance of the small noncleaved cell subtype (32 cases, 60%); a smaller percentage of the lymphoblastic and large-cell subtypes (14 cases, 26% and 7 cases, 13%, respectively) were identified </plain></SENT>
<SENT sid="2" pm="."><plain>The frequencies of primary sites of involvement in descending order included 60% in abdomen, 19% in mediastinum, 15% in head/neck, and 4% in peripheral nodes </plain></SENT>
<SENT sid="3" pm="."><plain>The majority of children presented with advanced stage disease (St </plain></SENT>
<SENT sid="4" pm="."><plain>Jude stage III/IV/<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, 92.5%) </plain></SENT>
<SENT sid="5" pm="."><plain>Of interest, 8 of 15 (53%) small noncleaved cell NHL cases examined contained Epstein-Barr virus (EBV) </plain></SENT>
<SENT sid="6" pm="."><plain>The high frequency of EBV association in this study suggests that this virus may play a more global role in NHL pathogenesis than previously recognized </plain></SENT>
</text></document>